Crossing the quality chasm: A requirement for successful cervical cancer prevention in developing countries

Clinics in Laboratory Medicine

Volumn 24, Issue 4, 2004, Pages 945-963

  Suba, Eric J ^a  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PREVENTION; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; HEALTH CARE COST; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HUMAN; LABORATORY AUTOMATION; MASS SCREENING; PAPANICOLAOU TEST; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CANCER;

CYTODIAGNOSIS; DEVELOPING COUNTRIES; FEMALE; HUMANS; MASS SCREENING; PREVENTIVE HEALTH SERVICES; QUALITY ASSURANCE, HEALTH CARE; UTERINE CERVICAL NEOPLASMS;

EID: 9144249938     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2004.05.018     Document Type: Review

References (82)

1. P. Pisani, F. Bray, and D.M. Parkin Estimates of the world-wide prevalence of cancer for 25 sites in the adult population Int J Cancer 97 1 2002 72 81
2. B.W. Stewart P. Kleihues Global cancer report 2003 World Health Organization Geneva (Switzerland)
3. Agency for Healthcare Research and Quality. Screening for cervical cancer. Systematic evidence review number 25. January 2002. Available at: http://www.ahrq.gov/clinic/prev/crvcainv.htm. Accessed March 1, 2004.
4. E.J. Suba, and S.S. Raab The Viet/American Cervical Cancer Prevention Project. Papanicolaou screening in developing countries: an idea whose time has come Am J Clin Pathol 121 3 2004 315 320
5. A.B. Miller Quality assurance in screening strategies. Review Virus Res 89 2 2002 295 299
6. Committee on Quality of Health Care in America Crossing the quality chasm: a new health system for the 21st century 2001 National Academy Press Washington, DC
7. Institute of Medicine K.N. Lohr Medicare: a strategy for quality assurance 1990 National Academy Press Washington, DC
8. R.W. Brown Why is quality assurance so difficult? A review of issues in quality assurance over the last decade Intern Med J 32 7 2002 331 337
9. L.I. Iezzoni Monitoring quality of care: what do we need to know? Inq 30 1993 112 114
10. A.A. Renshaw Rescreening in cervical cytology for quality control. When bad data is worse than no data or what works, what doesn't, and why Clin Lab Med 23 3 2003 695 708
11. E.J. Suba, and S.S. Raab The Viet/American Cervical Cancer Prevention Project. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam [author reply] Cancer 94 8 2002 2314 2316
12. A. Donabedian Evaluating the quality of medical care Milbank Mem Fund Q 44 1966 166 203
13. S. Arrossi, R. Sankaranarayanan, and D.M. Parkin Incidence and mortality of cervical cancer in Latin America Salud Publica Mex 45 Suppl 3 2003 S306 S314
14. D.M. Parkin, F.I. Bray, and S.S. Devesa Cancer burden in the year 2000. The global picture Eur J Cancer 37 2001 s4 s66
15. D.M. Parkin The epidemiological basis for evaluating screening policies E. Franco J. Monsonego New developments in cervical cancer screening and prevention 1997 Blackwell Sciences Oxford (U.K.) 51 69
16. S.C. Robles, F. White, and A. Peruga Trends in cervical cancer mortality in the Americas Bull Pan Am Health Organ 30 2002 290 301
17. Institute of Medicine Measuring the quality of health care M.S. Donaldson 1999 National Academy Press Washington, DC
18. A. Flisser, F. Garcia-Malo, L. Canepa Mde, S. Doncel, R. Espinoza, and R. Moreno Implementation and evaluation of a national external quality control program for cervical cytology in Mexico Salud Publica Mex 44 5 2002 431 436
19. F. Garcia, E. Mendez de Galaz, S. Baldwin, M. Papenfuss, A.R. Giuliano, and K. Hatch Factors that affect the quality of cytologic cervical cancer screening along the Mexico-United States border Am J Obstet Gynecol 189 2 2003 467 472
20. J. Ponten, H.O. Adami, R. Bergstrom, J. Dillner, L.G. Friberg, and L. Gustafsson Strategies for global control of cervical cancer Int J Cancer 60 1995 1 26
21. L.D. Marrett, S. Robles, F.D. Ashbury, B. Green, V. Goel, and S. Luciani A proposal for cervical screening information systems in developing countries Int J Cancer 102 3 2002 293 299
22. A.B. Miller Cervical cancer screening programmes: technical guidelines 1988 World Health Organization Geneva (Switzerland)
23. J. Stjernsward, D. Eddy, U. Luthra, and K. Stanley Plotting a new course for cervical cancer screening in developing countries World Health Forum 8 1987 42 45
24. L.W. Pickle, and R.G. Gillum Geographic variation in cardiovascular disease mortality in US blacks and whites J Natl Med Assoc 91 10 1999 545 556
25. P.T. Hoang Anh, D.M. Parkin, N.T. Hanh, and N.B. Duc Cancer in the population of Hanoi, Vietnam, 1988-1990 Br J Cancer 68 1993 1236 1242
26. N.M. Quoc, N.C. Hung, and D.M. Parkin Cancer incidence in Ho Chi Minh City, Vietnam, 1995-1996 Int J Cancer 76 1998 472 479
27. P.T.H. Anh, N.T. Hieu, R. Herrero, S. Vaccarella, J.S. Smith, and N.T. Thuy Human papillomavirus infection among women in South and North Vietnam Int J Cancer 104 2 2003 213 220
28. M.L.D. Huynh, S.S. Raab, and E.J. Suba Association between war and cervical cancer among Vietnamese women Int J Cancer 2004 in press
29. E.J. Suba, N.C. Hung, N.B. Duc, and S.S. Raab Viet/American Cervical Cancer Prevention Project. De novo establishment and cost-effectiveness of Papanicolaou cytology screening services in the Socialist Republic of Vietnam Cancer 91 5 2001 928 939
30. A.B. Miller Cervical cancer screening programmes: managerial guidelines 1992 World Health Organization Geneva (Switzerland)
31. Australian Institute of Health and Welfare. Cervical screening in Australia, 1998-1999. Available at: http://www.aihw.gov.au/publications/can/ csa98-99/index.html. Accessed March 1, 2004.
32. A.A. Renshaw Measuring sensitivity in gynecologic cytology: a review Cancer 96 4 2002 210 217
33. D.D. Davey, E. McGoogan, T.M. Somrak, K.A. Allen, D. Beccati, and S.F. Cramer Competency assessment and proficiency testing Acta Cytol 44 6 2000 939 943
34. United States Congress. Clinical laboratory improvement amendments of 1988 (CLIA). Washington, DC; 1988. House Report 100-899.
35. W.M. Hindman An approach to the problem of false negatives in gynecologic cytologic screening Acta Cytol 33 6 1989 814 818
36. D. Brooke, N. Dudding, and J. Sutton Rapid (partial) prescreening of cervical smears: the quality control method of choice? Cytopathology 13 4 2002 191 199
37. A.A. Renshaw, B. Bellerose, S.A. DiNisco, L.J. Minter, and K.R. Lee False negative rate of cervical cytologic smear screening as determined by rapid rescreening Acta Cytol 43 3 1999 344 350
38. M. Arbyn, U. Schenck, E. Ellison, and A. Hanselaar Metaanalysis of the accuracy of rapid prescreening relative to full screening of pap smears Cancer 99 1 2003 9 16
39. E.J. Johnson National Co-ordinator of the NHS Cervical Screening Programme (NHSCSP). Achievable standards, benchmarks for reporting, and criteria for evaluating cervical cytopathology. 2nd edition including revised performance indicators Cytopathology 11 4 2000 212 241
40. P.A. Krieger, E. McGoogan, G.P. Vooijs, N.S. Amma, B. Cochand-Priollet, and T.J. Colgan Quality assurance/control issues. International Academy of Cytology Task Force summary. Diagnostic Cytology Towards the 21st Century: An International Expert Conference and Tutorial Acta Cytol 42 1 1998 133 140
41. B.A. Jones, and D.D. Davey Quality management in gynecologic cytology using interlaboratory comparison Arch Pathol Lab Med 124 5 2000 672 681
42. L.V. Xuan, P.D. Man, N.Q. Truc, N.M. Quoc, N.S. Trung, and V.V. Vu Establishment and cost-effectiveness of Pap smear screening services in a developing country [abstract] Mod Pathol 12 1999 189A
43. D.K. Gupta, G. Komaromy-Hiller, S.S. Raab, and M.E. Nath Interobserver and intraobserver variability in the cytologic diagnosis of normal and abnormal metaplastic squamous cells in pap smears Acta Cytol 45 5 2001 697 703
44. D.M. Berwick Quality of health care. Part 5: payment by capitation and the quality of care N Engl J Med 335 1996 1227 1231
45. M.R. Chassin, E.L. Hannan, and B.A. DeBuono Benefits and hazards of reporting medical outcomes publicly N Engl J Med 334 1996 394 398
46. United States Veterans Administration National Center for Patient Safety. Root cause analysis. Available at: http://www.patientsafety.gov/tools.html.
47. J.L. Condel, D.T. Sharbaugh, and S.S. Raab Error-free pathology: applying lean production methods to anatomic pathology Clin Lab Med 2004 in press
48. V. Schneider, M.R. Henry, M. Jiminez-Ayala, L.S. Turnbull, and T.C. Wright Cervical cancer screening, screening errors, and reporting Acta Cytol 45 2001 493 498
49. E. Lazcano-Ponce, P. Alonso, J.A. Ruiz-Moreno, and M. Hernandez-Avila Recommendations for cervical cancer screening programs in developing countries. The need for equity and technological development Salud Publica Mex 45 Suppl 3 2003 S449 S462
50. T.C. Wright Jr., J.T. Cox, L.S. Massad, L.B. Twiggs, and E.J. Wilkinson ASCCP-Sponsored Consensus Conference. 2001 consensus guidelines for the management of women with cervical cytological abnormalities JAMA 287 16 2002 2120 2129
51. R.M. Richart, R. Sankaranarayanan, S. Robles, and T.C. Wright Jr. Cervical cancer screening strategies for developing countries Contemp Ob/Gyn 71-79 2001 100 127
52. L. Denny, L. Kuhn, A. Pollack, H. Wainwright, and T.C. Wright Jr. Evaluation of alternative methods of cervical cancer screening for resource-poor settings Cancer 89 2000 826 833
53. L. Wang Developing countries put cervical cancer tests to the test J Natl Cancer Inst 94 2002 245 247
54. R. Robyr, S. Nazeer, P. Vassilakos, J.C. Matute, Z. Sando, and G. Halle Feasibility of cytology-based cervical cancer screening in rural Cameroon Acta Cytol 46 6 2002 1110 1116
55. J.L. Belinson, Y. Qiao, R. Pretorius, W. Zhang, K. Keaton, and P. Elson Prevalence of cervical cancer and feasibility of screening in rural China: a pilot study for the Shanxi Province Cervical Cancer Screening Study Int J Gynecol Cancer 9 5 1999 411 417
56. J. Belinson, Y.L. Qiao, R. Pretorius, W.H. Zhang, P. Elson, and L. Li Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia Gynecol Oncol 83 2 2001 439 444
57. Q. Pan, J.L. Belinson, L. Li, R.G. Pretorius, Y.L. Qiao, and W.H. Zhang A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study Acta Cytol 47 1 2003 45 50
58. M. Schiffman, R. Herrero, A. Hildesheim, M.E. Sherman, M. Bratti, and S. Wacholder HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica JAMA 283 1 2000 87 93
59. T.C. Wright Jr., L. Denny, L. Kuhn, A. Pollack, and A. Lorincz HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer JAMA 283 1 2000 81 86
60. University of Zimbabwe/JHPIEGO Cervical Cancer Project Visual inspection with acetic acid for cervical cancer screening: test qualities in a primary care setting Lancet 353 1999 869 873
61. K.R. Geisinger Obstacles to reducing cervical cancer in Vietnam Am J Clin Pathol 121 3 2004 313 314
62. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. Available at: http://www.wma.net/e/policy/pdf/17c.pdf. Accessed March 1, 2004.
63. L. Denny, L. Kuhn, A. Pollack, and T.C. Wright Jr. Direct visual inspection for cervical cancer screening Cancer 94 6 2002 1699 1707
64. T.C. Wright Jr., M. Menton, J.F. Myrtle, C. Chow, and A. Singer Visualization techniques (colposcopy, direct visual inspection, and spectroscopic and other visual methods). Summary of task force 7 Acta Cytol 46 5 2002 793 800
65. S.J. Goldie, L. Kuhn, L. Denny, A. Pollack, and T.C. Wright Policy analysis of cervical cancer screening strategies in low-resource settings: clinical benefits and cost-effectiveness JAMA 285 2001 3107 3115
66. J.S. Mandelblatt, W.F. Lawrence, L. Gaffikin, K.K. Limpahayom, P. Lumbiganon, and S. Warakamin Costs and benefits of different strategies to screen for cervical cancer in less-developed countries J Natl Cancer Inst 94 19 2002 1469 1483
67. R.H. Brook, and K.N. Lohr Efficacy, effectiveness, variations, and quality: boundary crossing research Med Care 23 1985 710 722
68. P. Sasieni, J. Cuzick, P. Boyle, P. Craddock, T. Hince, and H. Kitchener Routine audit is an ethical requirement of screening Br Med J 322 7295 2001 1179
69. S.J. Goldie, L. Kuhn, L. Denny, A. Pollack, and T.C. Wright Jr. Cervical cancer screening in developing countries [letter] JAMA 286 24 2001 3079 3081
70. J.L. Belinson, and R.G. Pretorius Cervical cancer screening by simple visual inspection after acetic acid [letter] Obstet Gynecol 99 3 2002 518
71. E.J. Suba, and S.S. Raab Direct visual inspection for cervical cancer screening Cancer 2004 in press
72. L. Kuhn, L. Denny, A. Pollack, A. Lorincz, R.M. Richart, and T.C. Wright Human papillomavirus DNA testing for cervical cancer screening in low-resource settings J Natl Cancer Inst 92 10 2000 818 825
73. J. Cuzick, A. Szarewski, H. Cubie, G. Hulman, H. Kitchener, and D. Luesley Management of women who test positive for high-risk types of human papillomavirus: the HART study Lancet 362 9399 2003 1871 1876
74. J. Coste, B. Cochand-Priollet, P. de Cremoux, C. Le Gales, I. Cartier, and V. Molinie Cross-sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening BMJ 326 2003 733 737
75. S.L. Kulasingam, J.P. Hughes, N.B. Kiviat, C. Mao, N.S. Weiss, and J.M. Kuypers Evaluation of human papillomavirus testing in primary screening for cervical abnormalities: comparison of sensitivity, specificity, and frequency of referral JAMA 288 14 2002 1749 1757
76. F. Davidoff, C.D. DeAngelis, J.M. Drazen, J. Hoey, L. Hojgaard, and R. Horton Sponsorship, authorship, and accountability JAMA 286 10 2001 1232 1234
77. J.E. Bekelman, Y. Li, and C.P. Gross Scope and impact of financial conflicts of interest in biomedical research: a systematic review JAMA 289 4 2003 454 465
78. J.L. Belinson, Y.L. Qiao, R.G. Pretorius, W.H. Zhang, S.D. Rong, and M.N. Huang Shanxi Province cervical cancer screening study II: self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology Int J Gynecol Cancer 13 6 2003 819 826
79. J. Salmeron, E. Lazcano-Ponce, A. Lorincz, M. Hernandez, P. Hernandez, and A. Leyva Comparison of HPV-based assays with Papanicolaou smears for cervical cancer screening in Morelos State, Mexico Cancer Causes Control 14 6 2003 505 512
80. The Appalachia Leadership Initiative on Cancer Sowing seeds in the mountains: community-based coalitions for cancer prevention and control 1994 National Cancer Institute Bethesda (MD) Publication #NIH 94-3779. p. 1
81. M.L. Hutchinson, D.J. Zahniser, M.E. Sherman, R. Herrero, M. Alfaro, and M.C. Bratti Utility of liquid-based cytology for cervical carcinoma screening: results of a population-based study conducted in a region of Costa Rica with a high incidence of cervical carcinoma Cancer 87 2 1999 48 55
82. S.D. Womack, Z.M. Chirenje, P.D. Blumenthal, L. Gaffikin, J.A. McGrath, and T. Chipato Evaluation of a human papillomavirus assay in cervical screening in Zimbabwe BJOG 107 1 2000 33 38